HIKMA PHARMACEUTICALS USA

CEFAZOLIN

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

HIKMA PHARMACEUTICALS USA

Cefazolin HCPCS:

J0688

HCPCS Code Descriptor:

Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg

Category:

J Code

Cefazolin NDCs:

00143-9139-25, 00143-9140-25

Primary Type:

Antibiotic

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intravenous

Cefazolin CPT Codes:

Some of the most common CPT administration codes for 'buy and bill' drugs can be found at the following link:

Potential NDC Listing Errors:

We have identified listing errors with the following NDCs:

00143-9140-25, 00143-9139-25

About Cefazolin:

CEFAZOLIN is a Antibiotic drug manufactured by HIKMA PHARMACEUTICALS USA and administered via the Intravenous route of administration. The J Code: J0688 is aligned to the drug CEFAZOLIN.

Cefazolin is a type of antibiotic used to treat a variety of bacterial infections. Cefazolin can be used to treat infections of the lungs, bones, joints, urinary tract, skin, genitals, and gallbladder, as well as infections in the heart and blood. It is also sometimes administered to patients before or after surgery as infection prevention. It works by either killing bacteria, or preventing growth.

ACCESS PRICING AND MORE BY REGISTERING

J0688 Added Date:

January 1, 2024

J0688 Effective Date:

January 1, 2024

J0688 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Cefazolin billing and coding information.
Our team did not identify a source for Cefazolin patient assistance information. Please reach out to our team if you feel that this is a mistake.
CEFAZOLIN prescribing information can be found at the link below:
Information regarding CEFAZOLIN’s side effects can be found at MedlinePlus